New immunotherapy approach for pancreatic cancer using micro-RNA-29a
A novel immunotherapy for pancreatic cancer using micro-RNA-29a
This study is testing a new treatment for pancreatic cancer that helps boost the immune system's ability to fight tumors by reviving important immune cells, and it's designed for patients looking for better options to improve their chances of survival.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-10997577 on NIH RePORTER |
What this research studies
This research investigates a novel immunotherapy for pancreatic cancer that focuses on enhancing the function of CD8 T cells, which are crucial for fighting tumors. The approach aims to counteract the exhaustion of these immune cells, which often occurs in the tumor environment, by using micro-RNA-29a to restore their ability to attack cancer cells. By combining this treatment with existing immune checkpoint blockade therapies, the goal is to improve patient outcomes and increase survival rates for those with pancreatic ductal adenocarcinoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma who have limited treatment options.
Not a fit: Patients with early-stage pancreatic cancer who can undergo surgery may not benefit from this immunotherapy approach.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment options and survival rates for patients with pancreatic cancer.
How similar studies have performed: Previous research has shown promise in using micro-RNA to enhance immune responses in other cancers, suggesting potential for success in this novel application.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Rafie, Christine Isabelle — University of Miami School of Medicine
- Study coordinator: Rafie, Christine Isabelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.